1 Antibiotic Resistance Market Overview 1.1 Antibiotic Resistance Product Overview 1.2 Antibiotic Resistance Market Segment by Type 1.2.1 Type I 1.2.2 Type II 1.3 Global Antibiotic Resistance Market Size by Type (2015-2026) 1.3.1 Global Antibiotic Resistance Market Size Overview by Type (2015-2026) 1.3.2 Global Antibiotic Resistance Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Antibiotic Resistance Sales Market Share Breakdown by Type (2015-2020) 1.3.2.2 Global Antibiotic Resistance Revenue Market Share Breakdown by Type (2015-2020) 1.3.2.3 Global Antibiotic Resistance Average Selling Price (ASP) by Type (2015-2020) 1.3.3 Global Antibiotic Resistance Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Antibiotic Resistance Sales Market Share Breakdown by Type (2021-2026) 1.3.3.2 Global Antibiotic Resistance Revenue Market Share Breakdown by Type (2021-2026) 1.3.3.3 Global Antibiotic Resistance Average Selling Price (ASP) by Type (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Antibiotic Resistance Sales Breakdown by Type (2015-2020) 1.4.2 Europe Antibiotic Resistance Sales Breakdown by Type (2015-2020) 1.4.3 Asia-Pacific Antibiotic Resistance Sales Breakdown by Type (2015-2020) 1.4.4 Latin America Antibiotic Resistance Sales Breakdown by Type (2015-2020) 1.4.5 Middle East and Africa Antibiotic Resistance Sales Breakdown by Type (2015-2020) 2 Global Antibiotic Resistance Market Competition by Company 2.1 Global Top Players by Antibiotic Resistance Sales (2015-2020) 2.2 Global Top Players by Antibiotic Resistance Revenue (2015-2020) 2.3 Global Top Players Antibiotic Resistance Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Antibiotic Resistance Manufacturing Base Distribution, Sales Area, Product Type 2.5 Antibiotic Resistance Market Competitive Situation and Trends 2.5.1 Antibiotic Resistance Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Antibiotic Resistance Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2019) 2.7 Date of Key Manufacturers Enter into Antibiotic Resistance Market 2.8 Key Manufacturers Antibiotic Resistance Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Antibiotic Resistance by Region (2015-2026) 3.1 Global Antibiotic Resistance Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Antibiotic Resistance Market Size Market Share by Region (2015-2020) 3.2.1 Global Antibiotic Resistance Sales Market Share by Region (2015-2020) 3.2.2 Global Antibiotic Resistance Revenue Market Share by Region (2015-2020) 3.2.3 Global Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Antibiotic Resistance Market Size Market Share by Region (2021-2026) 3.3.1 Global Antibiotic Resistance Sales Market Share by Region (2021-2026) 3.3.2 Global Antibiotic Resistance Revenue Market Share by Region (2021-2026) 3.3.3 Global Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2021-2026) 4 Global Antibiotic Resistance by Application 4.1 Antibiotic Resistance Segment by Application 4.1.1 Oxazolidinones 4.1.2 Lipoglycopeptides 4.1.3 Tetracyclines 4.1.4 Cephalosporins 4.1.5 Combination therapies 4.1.6 Other 4.2 Global Antibiotic Resistance Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Antibiotic Resistance Historic Sales by Application (2015-2020) 4.4 Global Antibiotic Resistance Forecasted Sales by Application (2021-2026) 4.5 Key Regions Antibiotic Resistance Market Size by Application 4.5.1 North America Antibiotic Resistance by Application 4.5.2 Europe Antibiotic Resistance by Application 4.5.3 Asia-Pacific Antibiotic Resistance by Application 4.5.4 Latin America Antibiotic Resistance by Application 4.5.5 Middle East and Africa Antibiotic Resistance by Application 5 North America Antibiotic Resistance Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Antibiotic Resistance Sales Market Share by Country (2015-2020) 5.1.2 North America Antibiotic Resistance Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Antibiotic Resistance Sales Market Share by Country (2021-2026) 5.2.2 North America Antibiotic Resistance Revenue Market Share by Country (2021-2026) 6 Europe Antibiotic Resistance Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Antibiotic Resistance Sales Market Share by Country (2015-2020) 6.1.2 Europe Antibiotic Resistance Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Antibiotic Resistance Sales Market Share by Country (2021-2026) 6.2.2 Europe Antibiotic Resistance Revenue Market Share by Country (2021-2026) 7 Asia-Pacific Antibiotic Resistance Market Size by Region (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Region (2015-2020) 7.1.1 Asia-Pacific Antibiotic Resistance Sales Market Share by Region (2015-2020) 7.1.2 Asia-Pacific Antibiotic Resistance Revenue Market Share by Region (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Region (2021-2026) 7.2.1 Asia-Pacific Antibiotic Resistance Sales Market Share by Region (2021-2026) 7.2.2 Asia-Pacific Antibiotic Resistance Revenue Market Share by Region (2021-2026) 8 Latin America Antibiotic Resistance Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Antibiotic Resistance Sales Market Share by Country (2015-2020) 8.1.2 Latin America Antibiotic Resistance Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Antibiotic Resistance Sales Market Share by Country (2021-2026) 8.2.2 Latin America Antibiotic Resistance Revenue Market Share by Country (2021-2026) 9 Middle East and Africa Antibiotic Resistance Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2021-2026) 10 Company Profiles and Key Figures in Antibiotic Resistance Business 10.1 Allergan 10.1.1 Allergan Corporation Information 10.1.2 Allergan Description, Business Overview 10.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.1.4 Allergan Antibiotic Resistance Products Offered 10.1.5 Allergan Recent Developments 10.2 AmpliPhi Biosciences 10.2.1 AmpliPhi Biosciences Corporation Information 10.2.2 AmpliPhi Biosciences Description, Business Overview 10.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.2.4 Allergan Antibiotic Resistance Products Offered 10.2.5 AmpliPhi Biosciences Recent Developments 10.3 BioVersys GmbH 10.3.1 BioVersys GmbH Corporation Information 10.3.2 BioVersys GmbH Description, Business Overview 10.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.3.4 BioVersys GmbH Antibiotic Resistance Products Offered 10.3.5 BioVersys GmbH Recent Developments 10.4 Macrolide Pharmaceuticals 10.4.1 Macrolide Pharmaceuticals Corporation Information 10.4.2 Macrolide Pharmaceuticals Description, Business Overview 10.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered 10.4.5 Macrolide Pharmaceuticals Recent Developments 10.5 Melinta Therapeutics 10.5.1 Melinta Therapeutics Corporation Information 10.5.2 Melinta Therapeutics Description, Business Overview 10.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered 10.5.5 Melinta Therapeutics Recent Developments 10.6 Merck 10.6.1 Merck Corporation Information 10.6.2 Merck Description, Business Overview 10.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.6.4 Merck Antibiotic Resistance Products Offered 10.6.5 Merck Recent Developments 10.7 Nabriva Therapeutics 10.7.1 Nabriva Therapeutics Corporation Information 10.7.2 Nabriva Therapeutics Description, Business Overview 10.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered 10.7.5 Nabriva Therapeutics Recent Developments 10.8 Nemesis Bioscience 10.8.1 Nemesis Bioscience Corporation Information 10.8.2 Nemesis Bioscience Description, Business Overview 10.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered 10.8.5 Nemesis Bioscience Recent Developments 10.9 Phage Technologies S.A 10.9.1 Phage Technologies S.A Corporation Information 10.9.2 Phage Technologies S.A Description, Business Overview 10.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered 10.9.5 Phage Technologies S.A Recent Developments 10.10 Tetraphase Pharmaceuticals 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Antibiotic Resistance Product Category, Application and Specification 10.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue, Price and Gross Margin (2015-2020) 10.10.4 Main Business Overview 10.10.5 Tetraphase Pharmaceuticals Recent Developments 10.11 The Medicines Company 10.11.1 The Medicines Company Corporation Information 10.11.2 The Medicines Company Description, Business Overview 10.11.3 The Medicines Company Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.11.4 The Medicines Company Antibiotic Resistance Products Offered 10.11.5 The Medicines Company Recent Developments 10.12 TPfizer 10.12.1 TPfizer Corporation Information 10.12.2 TPfizer Description, Business Overview 10.12.3 TPfizer Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.12.4 TPfizer Antibiotic Resistance Products Offered 10.12.5 TPfizer Recent Developments 10.13 Westway Health 10.13.1 Westway Health Corporation Information 10.13.2 Westway Health Description, Business Overview 10.13.3 Westway Health Antibiotic Resistance Sales, Revenue and Gross Margin (2015-2020) 10.13.4 Westway Health Antibiotic Resistance Products Offered 10.13.5 Westway Health Recent Developments 11 Antibiotic Resistance Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Antibiotic Resistance Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Antibiotic Resistance Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Antibiotic Resistance Industry Trends 11.4.2 Antibiotic Resistance Market Drivers 11.4.3 Antibiotic Resistance Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Players of Type I Table 2. Major Players of Type II Table 3. Global Antibiotic Resistance Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 4. Global Antibiotic Resistance Sales (K Pcs) by Type (2015-2020) (K Pcs) Table 5. Global Antibiotic Resistance Sales Share by Type (2015-2020) Table 6. Global Antibiotic Resistance Revenue (Million USD) by Type (2015-2020) Table 7. Global Antibiotic Resistance Revenue Share by Type (2015-2020) Table 8. Global Antibiotic Resistance Average Selling Price (ASP) (USD/Pcs) by Type (2015-2020) Table 9. Global Antibiotic Resistance Sales by Type (2021-2026) (K Pcs) Table 10. Global Antibiotic Resistance Sales Share by Type (2021-2026) Table 11. Global Antibiotic Resistance Revenue (US$ Million) by Type (2021-2026) Table 12. Global Antibiotic Resistance Revenue Share by Type (2021-2026) Table 13. Global Antibiotic Resistance Average Selling Price (ASP) (USD/Pcs) by Type (2021-2026) Table 14. North America Antibiotic Resistance Sales (USD/Pcs) by Type (2015-2020) Table 15. Europe Antibiotic Resistance Sales (USD/Pcs) by Type (2015-2020) Table 16. Asia-Pacific Antibiotic Resistance Sales (USD/Pcs) by Type (2015-2020) Table 17. Latin America Antibiotic Resistance Sales (USD/Pcs) by Type (2015-2020) Table 18. Middle East and Africa Antibiotic Resistance Sales (USD/Pcs) by Type (2015-2020) Table 19. Global Antibiotic Resistance Sales (K Pcs) by Company (2015-2020) Table 20. Global Antibiotic Resistance Sales Share by Company (2015-2020) Table 21. Global Antibiotic Resistance Revenue (Million US$) by Company (2015-2020) Table 22. Global Antibiotic Resistance Revenue Share by Company (2015-2020) Table 23. Global Market Antibiotic Resistance Average Selling Price (USD/Pcs) by Company (2015-2020) Table 24. Global Antibiotic Resistance Top Manufacturers Manufacturing Base Distribution and Sales Area Table 25. Global Antibiotic Resistance Top Manufacturers Product Category Table 26. Global Antibiotic Resistance Manufacturers Market Concentration Ratio (CR5 and HHI) Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotic Resistance as of 2019 Table 28. Date of Key Manufacturers Enter into Antibiotic Resistance Market Table 29. Key Manufacturers Antibiotic Resistance Product Type Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Antibiotic Resistance Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 32. Global Antibiotic Resistance Sales (K Pcs) by Region (2015-2020) Table 33. Global Antibiotic Resistance Sales Market Share by Region (2015-2020) Table 34. Global Antibiotic Resistance Revenue (US$ Million) by Region (2015-2020) Table 35. Global Antibiotic Resistance Revenue Market Share by Region (2015-2020) Table 36. Global Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 37. Global Antibiotic Resistance Sales (K Pcs) by Region (2021-2026) Table 38. Global Antibiotic Resistance Sales Market Share by Region (2021-2026) Table 39. Global Antibiotic Resistance Revenue (US$ Million) by Region (2021-2026) Table 40. Global Antibiotic Resistance Revenue Market Share by Region (2021-2026) Table 41. Global Antibiotic Resistance Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 42. Global Antibiotic Resistance Sales (K Pcs) by Application: 2015 VS 2020 VS 2026 Table 43. Global Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 44. Global Antibiotic Resistance Sales Share by Application (2015-2020) Table 45. Global Antibiotic Resistance Sales (K Pcs) by Application (2021-2026) Table 46. Global Antibiotic Resistance Sales Share by Application (2021-2026) Table 47. North America Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 48. North America Sales Antibiotic Resistance Market Share by Application (2015-2020) Table 49. Europe Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 50. Europe Sales Antibiotic Resistance Market Share by Application In 2019 Table 51. Asia-Pacific Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 52. Asia-Pacific Sales Antibiotic Resistance Market Share by Application In 2019 Table 53. Latin America Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 54. Latin America Sales Antibiotic Resistance Market Share by Application In 2019 Table 55. Middle East and Africa Antibiotic Resistance Sales (K Pcs) by Application (2015-2020) Table 56. Middle East and Africa Antibiotic Resistance Sales Share by Application (2015-2020) Table 57. North America Antibiotic Resistance Sales (K Pcs) by Country (2015-2020) Table 58. North America Antibiotic Resistance Sales Market Share by Country (2015-2020) Table 59. North America Antibiotic Resistance Revenue (US$ Million) by Country (2015-2020) Table 60. North America Antibiotic Resistance Revenue Market Share by Country (2015-2020) Table 61. North America Antibiotic Resistance Sales (K Pcs) by Country (2021-2026) Table 62. North America Antibiotic Resistance Sales Market Share by Country (2021-2026) Table 63. North America Antibiotic Resistance Revenue (US$ Million) by Country (2021-2026) Table 64. North America Antibiotic Resistance Revenue Market Share by Country (2021-2026) Table 65. Europe Antibiotic Resistance Sales (K Pcs) by Country (2015-2020) Table 66. Europe Antibiotic Resistance Sales Market Share by Country (2015-2020) Table 67. Europe Antibiotic Resistance Revenue (US$ Million) by Country (2015-2020) Table 68. Europe Antibiotic Resistance Revenue Market Share by Country (2015-2020) Table 69. Europe Antibiotic Resistance Sales (K Pcs) by Country (2021-2026) Table 70. Europe Antibiotic Resistance Sales Market Share by Country (2021-2026) Table 71. Europe Antibiotic Resistance Revenue (US$ Million) by Country (2021-2026) Table 72. Europe Antibiotic Resistance Revenue Market Share by Country (2021-2026) Table 73. Asia-Pacific Antibiotic Resistance Sales (K Pcs) by Region (2015-2020) Table 74. Asia-Pacific Antibiotic Resistance Sales Market Share by Region (2015-2020) Table 75. Asia-Pacific Antibiotic Resistance Revenue (US$ Million) by Region (2015-2020) Table 76. Asia-Pacific Antibiotic Resistance Revenue Market Share by Region (2015-2020) Table 77. Asia-Pacific Antibiotic Resistance Sales (K Pcs) by Region (2021-2026) Table 78. Asia-Pacific Antibiotic Resistance Sales Market Share by Region (2021-2026) Table 79. Asia-Pacific Antibiotic Resistance Revenue (US$ Million) by Region (2021-2026) Table 80. Asia-Pacific Antibiotic Resistance Revenue Market Share by Region (2021-2026) Table 81. Latin America Antibiotic Resistance Sales (K Pcs) by Country (2015-2020) Table 82. Latin America Antibiotic Resistance Sales Market Share by Country (2015-2020) Table 83. Latin America Antibiotic Resistance Revenue (US$ Million) by Country (2015-2020) Table 84. Latin America Antibiotic Resistance Revenue Market Share by Country (2015-2020) Table 85. Latin America Antibiotic Resistance Sales (K Pcs) by Country (2021-2026) Table 86. Latin America Antibiotic Resistance Sales Market Share by Country (2021-2026) Table 87. Latin America Antibiotic Resistance Revenue (US$ Million) by Country (2021-2026) Table 88. Latin America Antibiotic Resistance Revenue Market Share by Country (2021-2026) Table 89. Middle East and Africa Antibiotic Resistance Sales (K Pcs) by Country (2015-2020) Table 90. Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2015-2020) Table 91. Middle East and Africa Antibiotic Resistance Revenue (US$ Million) by Country (2015-2020) Table 92. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2015-2020) Table 93. Middle East and Africa Antibiotic Resistance Sales (K Pcs) by Country (2021-2026) Table 94. Middle East and Africa Antibiotic Resistance Sales Market Share by Country (2021-2026) Table 95. Middle East and Africa Antibiotic Resistance Revenue (US$ Million) by Country (2021-2026) Table 96. Middle East and Africa Antibiotic Resistance Revenue Market Share by Country (2021-2026) Table 97. Allergan Corporation Information Table 98. Allergan Description and Business Overview Table 99. Allergan Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 100. Allergan Antibiotic Resistance Product Table 101. Allergan Recent Developments Table 102. AmpliPhi Biosciences Corporation Information Table 103. AmpliPhi Biosciences Description and Business Overview Table 104. AmpliPhi Biosciences Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 105. AmpliPhi Biosciences Antibiotic Resistance Product Table 106. AmpliPhi Biosciences Recent Developments Table 107. BioVersys GmbH Corporation Information Table 108. BioVersys GmbH Description and Business Overview Table 109. BioVersys GmbH Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 110. BioVersys GmbH Antibiotic Resistance Product Table 111. BioVersys GmbH Recent Developments Table 112. Macrolide Pharmaceuticals Corporation Information Table 113. Macrolide Pharmaceuticals Description and Business Overview Table 114. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 115. Macrolide Pharmaceuticals Antibiotic Resistance Product Table 116. Macrolide Pharmaceuticals Recent Developments Table 117. Melinta Therapeutics Corporation Information Table 118. Melinta Therapeutics Description and Business Overview Table 119. Melinta Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 120. Melinta Therapeutics Antibiotic Resistance Product Table 121. Melinta Therapeutics Recent Developments Table 122. Merck Corporation Information Table 123. Merck Description and Business Overview Table 124. Merck Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 125. Merck Antibiotic Resistance Product Table 126. Merck Recent Developments Table 127. Nabriva Therapeutics Corporation Information Table 128. Nabriva Therapeutics Description and Business Overview Table 129. Nabriva Therapeutics Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 130. Nabriva Therapeutics Antibiotic Resistance Product Table 131. Nabriva Therapeutics Recent Developments Table 132. Nemesis Bioscience Corporation Information Table 133. Nemesis Bioscience Description and Business Overview Table 134. Nemesis Bioscience Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 135. Nemesis Bioscience Antibiotic Resistance Product Table 136. Nemesis Bioscience Recent Developments Table 137. Phage Technologies S.A Corporation Information Table 138. Phage Technologies S.A Description and Business Overview Table 139. Phage Technologies S.A Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 140. Phage Technologies S.A Antibiotic Resistance Product Table 141. Phage Technologies S.A Recent Developments Table 142. Tetraphase Pharmaceuticals Corporation Information Table 143. Tetraphase Pharmaceuticals Description and Business Overview Table 144. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 145. Tetraphase Pharmaceuticals Antibiotic Resistance Product Table 146. Tetraphase Pharmaceuticals Recent Developments Table 147. The Medicines Company Corporation Information Table 148. The Medicines Company Description and Business Overview Table 149. The Medicines Company Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 150. The Medicines Company Antibiotic Resistance Product Table 151. The Medicines Company Recent Developments Table 152. TPfizer Corporation Information Table 153. TPfizer Description and Business Overview Table 154. TPfizer Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 155. TPfizer Antibiotic Resistance Product Table 156. TPfizer Recent Developments Table 157. Westway Health Corporation Information Table 158. Westway Health Description and Business Overview Table 159. Westway Health Antibiotic Resistance Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020) Table 160. Westway Health Antibiotic Resistance Product Table 161. Westway Health Recent Developments Table 162. Key Raw Materials Lists Table 163. Raw Materials Key Suppliers Lists Table 164. Antibiotic Resistance Opportunities and Drivers Table 165. Antibiotic Resistance Market Challenges Table 166. Antibiotic Resistance Market Risks Table 167. Distributors List Table 168. Antibiotic Resistance Downstream Customers Table 169. Research Programs/Design for This Report Table 170. Key Data Information from Secondary Sources Table 171. Key Data Information from Primary Sources List of Figures Figure 1. Antibiotic Resistance Product Picture Figure 2. Global Antibiotic Resistance Market Size (Value), (illion USD), 2015 VS 2020 VS 2026 Figure 3. Global Antibiotic Resistance Revenue (Million USD) Status and Outlook (2015-2026) Figure 4. Global Antibiotic Resistance Sales (K Pcs) Status and Outlook (2015-2026) Figure 5. Product Picture of Type I Figure 6. Global Type I Sales (K Pcs) and Growth Rate (2015-2020) Figure 7. Product Picture of Type II Figure 8. Global Type II Sales (K Pcs): YoY Growth (2015-2020) Figure 9. Global Antibiotic Resistance Revenue and Growth Rate by Type (US$ Million) (2015-2026) Figure 10. Global Antibiotic Resistance Sales Market Share by Type in 2019 Figure 11. Global Antibiotic Resistance Revenue Share by Type (2015-2020) Figure 12. Global Antibiotic Resistance Revenue Market Share by Type in 2019 Figure 13. Global Antibiotic Resistance Sales Market Share by Type (2021-2026) Figure 14. Global Antibiotic Resistance Sales Market Share by Type In 2019 Figure 15. Global Antibiotic Resistance Revenue Share by Type (2021-2026) Figure 16. Global Antibiotic Resistance Revenue Market Share by Type In 2019 Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibiotic Resistance Sales in 2019 Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibiotic Resistance Revenue in 2019 Figure 19. Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 21. Oxazolidinones Examples Figure 22. Lipoglycopeptides Examples Figure 23. Tetracyclines Examples Figure 24. Cephalosporins Examples Figure 25. Combination therapies Examples Figure 26. Other Examples Figure 27. Key Raw Materials Price Figure 28. Antibiotic Resistance Manufacturing Cost Structure Figure 29. Antibiotic Resistance Industrial Chain Analysis Figure 30. Porter's Five Forces Analysis Figure 31. Channels of Distribution Figure 32. Distributors Profiles Figure 33. Bottom-up and Top-down Approaches for This Report Figure 34. Data Triangulation Figure 35. Key Executives Interviewed

Allergan AmpliPhi Biosciences BioVersys GmbH Macrolide Pharmaceuticals Melinta Therapeutics Merck Nabriva Therapeutics Nemesis Bioscience Phage Technologies S.A Tetraphase Pharmaceuticals The Medicines Company TPfizer Westway Health